Dexcom (Nasdaq:DXCM) announced today that, following the conclusion of the third quarter, it submitted G7 CGM to the FDA.

January AI today unveiled new advancements to its AI-driven metabolic health app that helps users monitor and take control of ...

BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity ...

Luna Diabetes announced that it launched its pivotal trial for Luna, the company's miniature automated insulin delivery ...

Know Labs (NYSE:KNW) announced today that it appointed a new chief science officer (CSO) and interim chief technology officer ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

ViCentra announced that it received CE mark approval for its Kaleido insulin pump under European Medical Device Regulation ...

Ypsomed announced today that it opened a new production hall at its German site in Schwerin to increase auto-injector ...

Medtronic (NYSE: MDT) announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated ...

Clearside Biomedical today announced that the ODYSSEY study of its drug-device combination achieved its primary and secondary ...